Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 2006;47:568-572
Published online before print January 9, 2006, doi: 10.1161/01.HYP.0000200027.34925.93
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
47/3/568    most recent
01.HYP.0000200027.34925.93v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kopkan, L.
Right arrow Articles by Majid, D. S.A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kopkan, L.
Right arrow Articles by Majid, D. S.A.
Related Collections
Right arrow Other hypertension

(Hypertension. 2006;47:568.)
© 2006 American Heart Association, Inc.


Part 2 Original Articles

Enhanced Superoxide Activity Modulates Renal Function in NO-Deficient Hypertensive Rats

Libor Kopkan; Dewan S.A. Majid

From the Department of Physiology, Tulane Hypertension and Renal Center of Excellence, Tulane University Health Sciences Center, New Orleans, La.

Correspondence to Dewan S.A. Majid, Department of Physiology, SL 39, Tulane University Health Sciences Center, 1430 Tulane Ave, New Orleans, LA 70112. E-mail majid{at}tulane.edu

An enhancement of superoxide (O2) activity was shown to contribute to the development of hypertension induced by NO deficiency. To better understand the mechanistic role of O2 in this NO-deficient hypertension, we evaluated the renal responses to acute intraarterial administration of an O2 scavenger, tempol (50 µg/min per 100 g of body weight) in anesthetized male Sprague-Dawley rats treated with NO synthase inhibitor nitro-L-arginine methyl ester (15 mg/kg per day in drinking water, n=7) for 4 weeks, which caused increases in mean arterial pressure (146±3 versus 124±2 mm Hg) compared with normotensive control rats (n=6). Hypertensive rats had higher renal vascular resistance (29±2 versus 20±1 mm Hg/mL per minute per gram), as well as lower renal blood flow (5.2±0.3 versus 6.3±0.2 mL/min per gram; cortical blood flow, 153±13 versus 191±8 perfusion units; medullary blood flow, 43±2 versus 51±3 perfusion units) and glomerular filtration rate (0.69±0.04 versus 0.90±0.05 mL/min per gram) without a significant difference in urinary sodium excretion (0.81±0.07 versus 0.86±0.12 µmol/min per gram) compared with normotensive rats. Urinary 8-isoprostane excretion rate (6.8±0.7 versus 4.5±0.3 pg/min per gram) was higher in hypertensive than normotensive rats. Intraarterial infusion of tempol did not alter renal function in normotensive rats. However, tempol significantly decreased renal vascular resistance by 12±2% and urinary 8-isoprostane excretion rate by 24±4% and increased renal blood flow by 10±2%, cortical blood flow by 9±2%, medullary blood flow by 15±6%, glomerular filtration rate by 11±3%, and urinary sodium excretion by 19±5% in hypertensive rats. These data indicate that enhanced O2 activity modulates renal hemodynamics and excretory function during reduced NO production and, thus, contributes to the pathophysiology of the NO-deficient form of hypertension.


Key Words: nitric oxide • oxidative stress • hypertension, renal




This article has been cited by other articles:


Home page
Am. J. Physiol. Renal Physiol.Home page
L. C. Matavelli, P. J. Kadowitz, L. G. Navar, and D. S. A. Majid
Renal hemodynamic and excretory responses to intra-arterial infusion of peroxynitrite in anesthetized rats
Am J Physiol Renal Physiol, January 1, 2009; 296(1): F170 - F176.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
M. Shahid, J. Francis, and D. S. A. Majid
Tumor necrosis factor-{alpha} induces renal vasoconstriction as well as natriuresis in mice
Am J Physiol Renal Physiol, December 1, 2008; 295(6): F1836 - F1844.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
M. Z. Haque and D. S. A. Majid
Reduced renal responses to nitric oxide synthase inhibition in mice lacking the gene for gp91phox subunit of NAD(P)H oxidase
Am J Physiol Renal Physiol, September 1, 2008; 295(3): F758 - F764.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
J. M. Moreno, I. Rodriguez Gomez, R. Wangensteen, M. Alvarez-Guerra, J. d. D. Luna, J. Garcia-Estan, and F. Vargas
Tempol improves renal hemodynamics and pressure natriuresis in hyperthyroid rats
Am J Physiol Regulatory Integrative Comp Physiol, March 1, 2008; 294(3): R867 - R873.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
X. Chen, K. Patel, S. G. Connors, M. Mendonca, W. J. Welch, and C. S. Wilcox
Acute antihypertensive action of Tempol in the spontaneously hypertensive rat
Am J Physiol Heart Circ Physiol, December 1, 2007; 293(6): H3246 - H3253.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
W. J. Welch, K. Patel, P. Modlinger, M. Mendonca, N. Kawada, K. Dennehy, S. Aslam, and C. S. Wilcox
Roles of vasoconstrictor prostaglandins, COX-1 and -2, and AT1, AT2, and TP receptors in a rat model of early 2K,1C hypertension
Am J Physiol Heart Circ Physiol, November 1, 2007; 293(5): H2644 - H2649.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
A. Just, A. J. M. Olson, C. L. Whitten, and W. J. Arendshorst
Superoxide mediates acute renal vasoconstriction produced by angiotensin II and catecholamines by a mechanism independent of nitric oxide
Am J Physiol Heart Circ Physiol, January 1, 2007; 292(1): H83 - H92.
[Abstract] [Full Text] [PDF]